Table 2.
Susceptibility data for common bacterial isolates to cotrimoxazole and other antimicrobials regardless of HIV or cotrimoxazole prophylaxis status.
| Resistant | Susceptible | P | Resistant | Susceptible | P | |
|---|---|---|---|---|---|---|
| n% | n% | n% | n% | |||
| Cotrimoxazole | Amoxycillin-clavulanic | |||||
| Bacteria isolates | ||||||
| E. coli | 54 (84.4) | 10 (15.6) | 0.1 | 27 (43.6) | 35 (56.4) | <0.001 |
| S. aureus | 14 (56.0) | 11 (44.0) | 3 (13.0) | 20 (87.0) | ||
| K. pneumoniae | 20 (74.1) | 7 (25.9) | 20 (83.3) | 4 (16.7) | ||
| P. aeruginosa | 7 (87.5) | 1 (12.5) | 6 (75.0) | 2 (25.0) | ||
| Proteus | 17 (80.9) | 4 (19.1) | 10 (47.6) | 11 (52.4) | ||
|
| ||||||
| Erythromycin | Ceftriaxone | |||||
| Bacteria isolates | ||||||
| E. coli | 2 (50.0) | 2 (50.0) | 16 (48.5) | 17 (51.5) | 0.08 | |
| S. aureus | 8 (57.1) | 6 (42.9) | 4 (30.8) | 9 (69.2) | ||
| K. pneumoniae | 3 (60.0) | 2 (40.0) | 13 (72.2) | 5 (27.9) | ||
| P. aeruginosa | 0 (0.0) | 2 (100.0) | 1 (25.0) | 3 (75.0) | ||
| Proteus | — | — | 4 (33.3) | 8 (66.7) | ||
|
| ||||||
| Ciprofloxacin | Ampicillin | |||||
| Bacteria isolates | ||||||
| E. coli | 20 (32.8) | 41 (67.2) | 0.49 | 47 (82.5) | 10 (17.5) | 0.001 |
| S. aureus | 3 (13.6) | 19 (86.4) | 3 (30.0) | 7 (70.0) | ||
| K. pneumoniae | 6 (26.1) | 17 (73.9) | 21 (95.4) | 1 (4.6) | ||
| P. aeruginosa | 1 (16.7) | 5 (83.3) | 6 (75.0) | 2 (25.0) | ||
| Proteus | 5 (25.0) | 15 (75.0) | 16 (76.2) | 5 (23.8) | ||
|
| ||||||
| Tetracycline | Cefuroxime | |||||
| Bacteria isolates | ||||||
| E. coli | 29 (78.4) | 8 (21.6) | 0.03 | 11 (64.7) | 6 (35.3) | 0.60 |
| S. aureus | 4 (44.4) | 5 (55.6) | 3 (37.5) | 5 (62.5) | ||
| K. pneumoniae | 19 (95.0) | 1 (5.0) | 10 (71.4) | 4 (28.6) | ||
| P. aeruginosa | 5 (100.0) | 0 (0.0) | 2 (66.7) | 1 (33.3) | ||
| Proteus | 14 (82.4) | 3 (17.6) | 5 (45.5) | 6 (54.5) | ||